IGHE and asthma: Biologic therapies are monoclonal antibodies that target specific pathways of type 2 inflammation, such as interleukin (IL)-4, IL-5, IL-13, or immunoglobulin E (IgE), and are designed to reduce inflammation, improve asthma control, and minimize corticosteroid use in selected patients [2].